SPEAKERS' PROFILE
THEME : PREVENTION
Day 1 : 20 June 2025
[2.30pm - 4.00pm]
> Medical Professionals Track
Prof. Dr Rosmawati Mohamed
Consultant Hepatologist, Department of Internal Medicine,University Malaya Medical Centre
Dr Reynu Rajan
Surgeon, Avisena Specialist Hospital
Dr Mengmeng Li
Associate Professor,Sun Yat-sen University Cancer Center
> Allied Health Professionals Track
Ms. Ho Chiou Yi
Clinical Dietitian, National Cancer Institute
Prof. Edmund Sim Ui Hang
Professor,Universiti Malaysia Sarawak
Dr Luqman Mazlan
President,Asia-Pacific Federation of Coloproctology
> Determinants of Health Track
Ms Soo Sek Yow
Head of Nutrition Unit,Ace Canning Corporation Sdn Bhd
Assoc. Prof Dr Nur Amani binti Ahmad Tajuddin
lecturer/ clinician,Universiti Malaya
Datin Dr Noraslinah Hj Ramlee
Consultant Physician,Jerudong Park Medical Centre
> Research Track
Dr Ong Jue-Sheng
Team Head,QIMR Berghofer
Prof. Dr Hamid Jan bin Jan Mohamed
Professor,Universiti Sains Malaysia
Assoc. Prof. Dr. Mohd Razif Shahril
Associate Professor Dr,Universiti Kebangsaan Malaysia
THEME : SCREENING & DIAGNOSIS
Day 2 : 21 June 2025
[9.00am - 10.30am]
> Medical Professionals Track
Dato' Fitjerald A/L Henry
Professor, Sunway University
Dr Shivaani Mariapun
Postdoctoral Researcher, Cancer Research Malaysia
Dr Malwinder Singh Sandhu
Consultant Clinical Oncologist, Pantai Hospital Kuala Lumpur
> Allied Health Professionals Track
Ms. Ho Chiou Yi
Clinical Dietitian, National Cancer Institute
Prof. Dr Leong Chee-Onn
Chief Executive Officer, AGTC Genomics
Prof. Dr Anand Sachithanandan
Cardiothoracic Surgeon, Sunway Medical Centre
> Determinants of Health Track
Dr Ang Boon Hong
Post-doctoral Scientist, Cancer Research Malaysia
Dr Eliana Ahmad
Public Health Medicine Specialist, Ministry of Health Malaysia
Professor Ida Normiha Hilmi
Professor , University Malaya
> Research Track
Prof. Felicia Chung Fei Lei
Professor, Sunway University
Prof. Cheong Sok Ching
Chief Scientific Officer, Cancer Research Malaysia
A/Prof. Dr. Retnagowri Rajandram
Associate Professor , Universiti Malaya
THEME : TREATMENT
Day 2 : 21 June 2025
[2.00pm - 3.30pm]
> Medical Professionals Track
Prof. Dr. Ho Gwo Fuang
Consultant Clinical Oncologist , Curie Oncology KL
Dr Tan Chih Kiang
Consultant Clinical Oncologist, Picaso Hospital
Dr Nur Fadhlina Abdul Satar
Consultant Oncologist, Pantai Hospital Kuala Lumpur
> Allied Health Professionals Track
Dr Beverley Lim Hoeg
Psychologist and Researcher, Danish Cancer Institute
Mrs Betti Sharina binti Mohd Haniff Lai
Clinical Dietitian, Institut Kanser Negara
Dr Hadi Mohamad Abu Rasheed
Scientific Advisor, Head of the Professional Development and Research Department, Qatar Cancer Society
> Determinants of Health Track
Ms. Ishtar Espejo Castellá
Executive Director, Fundación Aladina
Prof Kenneth Kwing-Chin Lee
Professor of Health Economics, Monash University Malaysia
Dr Melissa Lim Siaw Han
Doctor of Philosophy, UNIMAS
> Research Track
Prof Yap Lee Fah
Professor, Universiti Malaya
Prof Goh Bey Hing
Professor & Head of Sunway Biofunctional Molecules Discovery Centre (SBMDC), Sunway University
Prof Dr Mai Chun Wai
Professor, Institute for Research, Development and Innovation (IRDI), IMU University
THEME : TREATMENT
Day 3 : 22 June 2025
[9.00am - 11.00am]
> Medical Professionals Track
Dr Voon Pei Jye
Consultant Medical Oncologist, Hospital Umum Sarawak (Sarawak General Hospital)
Ms. Harpreet Kaur A/P Darshan Singh
Executive Director, Malaysian Pharmacists Society
Dr Vijayan Munusamy
Clinical Specialist, University Malaya Medical Centre
> Allied Health Professionals Track
Dr Teh Kok Hoi
Pediatric Hemato-Oncologist, Hospital Kuala Lumpur
Ms. Betti Sharina
Dietitian, National Cancer Institute
Dr Arnil George Sirimanne
Doctor, Prince Court Medical Centre
> Determinants of Health Track
Prof Vetriselvan Subramaniyan
Professor and Deputy Dean of Internationalisation, Sir Jeffrey Cheah Sunway Medical School, Faculty of Medical and Life Sciences, Sunway University
Dr Anas Nofal
Chief Business Officer, Axios International
Dr Rahul Kapur
Vice President and Head of Medical Affairs, Biocon Biologics
> Research Track
Dr Akhmal Yusof
Chief Executive Officer, Clinical Research Malaysia
Prof. Dr Chin Kin Fah
Chairman and Founding Director, Academy of Silent Mentor
Dr Kong Li Ren
Assistant Professor of Cancer and Stem Cell Biology, Cancer Discovery and Regenerative Medicine Programme , Lee Kong Chian School of Medicine, Nanyang Technological University
THEME : SURVIVORSHIP
Day 3 : 22 June 2025
[11.00am - 12.30pm]
> Medical Professionals Track
Dr Saiful Adni bin Abd Latif
Doctor, Institut Kanser Negara
Dr Kenneth Voon KherTi
Consultant Colorectal Surgeon, Sarawak General Hospital
Assoc. Prof Dr Mohd Faizal Ahmad
Clinical Specialist & Lecturer of Obstetrician & Gynaecology, Hospital Canselor Tuanku Mukhriz Universiti Kebangsaan Malaysia (HCTM UKM)
> Allied Health Professionals Track
Dr Nur Nadiatul Asyikin binti Bujang
Dr, Pejabat Kesihatan Lembah Pantai
Dr. Lim Ren Jye
A. Professor, Sunway TCM Centre
Ms Tan Jie Sin
Dietitian, Sunway Medical Center
> Determinants of Health Track
Dr Gogillan Sevaratnam
Chair for Scientific Committee on Occupational Medicine, ICOH, Chair for Scientific Committee on Occupational Medicine, ICOH
Prof Dr Nirmala Bhoo Pathy
Professor , Universiti Malaya
Dr Abd Razak Muhamad
President, Max Family Society Malaysia
> Research Track
Associate Professor Dr. Caryn Mei Hsien Chan
Associate Professor , Universiti Kebangsaan Malaysia
Dr Mark Cheong Wing Loong
Deputy Head of School (Education), School of Pharmacy, Monash University Malaysia
Mrs Hoo Yee Yin
PhD Student, Department of social and preventive medicine University Malaya
side event: cancer financing summit day
Day 1 : 20 June 2025
Mr Abdullahi Sheriff
Managing Director, MSD Singapore, Malaysia & Brune
Mr Ragunath 'Pak Joe' Murthy
Founder & Chief RainMaker, reAInmaker
Mr Jonathan Teoh
Founder and CEO, KALSIS
Mr Alex Xia
Datuk Nuraslina Binti Zainal Abidin
Group Managing Director & Chief Executive Officer, Theta Edge Berhad
Mr Anesh Junak
Chief Product Officer, MCIS Life
Ms Dayang Miraffiorry Abu Husain
Childhood Cancer Program Coordinator, National Cancer Society Malaysia
Dr Vaishnavi Jeyasingam
Consultant Clinical Oncologist
side event: Designing Care Around the Individual Experience
Day 2 : 21 June 2025
Dr Hadi Abu Rasheed
Scientific Advisor and Head of the Professional Development and Scientific Research Department, Qatar Cancer Society
Dr. B. V. Murali Krishna
Oncologist, Hospital Lam Wah Ee
Mr. Francisco Freyria Sutcliffe
Chief Executive Officer, Fundación Fomento de Desarrollo Teresa de Jesús I.A.P. (FUTEJE)
Muhammad Shakir Abdul Aziz (Moderator)
Vice President, Hemophilia Society of Malaysia
Prof. Dr Rosmawati Mohamed
Consultant Hepatologist, Department of Internal Medicine,University Malaya Medical Centre
Professor Dr Rosmawati Mohamed, serving as a Consultant Hepatologist at the University Malaya Medical Centre, holds significant roles in global and regional hepatitis initiatives. She is the Founding Co-chairperson of the WHO Strategic and Technical Advisory Committee for Viral Hepatitis, contributing to global efforts in combating the disease. Locally, she assumes the role of Master at the Academy of Medicine of Malaysia, overseeing various medical specialties across the country. Actively involved in the Malaysian Medical Council, she influences policies regarding medical specialists’ recognition, training, and professional development. Additionally, she champions hepatitis and cancer advocacy as the President of Hepatitis Free Malaysia, reflecting her commitment to public health. Her multifaceted roles underscore her dedication to advancing healthcare both locally and globally.
Dr Reynu Rajan
Surgeon, Avisena Specialist Hospital
Dr. Reynu Rajan is a highly recognised Consultant Upper Gastrointestinal & Bariatric Surgeon with a strong reputation for clinical excellence and compassionate care. She completed her surgical training at Universiti Kebangsaan Malaysia (UKM) & advanced her expertise through subspecialty training in Taiwan and India. Dr. Reynu is a dedicated advocate for improving access to obesity treatment tirelessly working to reduce financial barriers for patients making life changing surgery accessible. As the principal advisor to the Bariatric Buddy Organization (BBO), she supports patients in their weight loss journeys and promotes holistic well-being. Dr. Reynu is also an active educator, contributing to both undergraduate & postgraduate surgical training & serving as co-chair for the writing committee of the 2022 Consensus. Statement on Patient & Procedure Selection for Bariatric Surgery in Malaysia. Her commitment to evidence-based practice and patient-centered care makes her a respected leader in her field.
Dr Mengmeng Li
Associate Professor,Sun Yat-sen University Cancer Center
Dr. Mengmeng Li is an associate professor in the Department of Cancer Prevention at Sun Yat-sen University Cancer Center (SYSUCC). Before joining SYSUCC in 2020 through the “100 Top Talents Program,” she served as a postdoctoral scientist at the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization (WHO).
As a cancer epidemiologist, Dr. Li is dedicated to advancing research on cancer prevention. She currently leads multiple national and provincial projects as the principal investigator. Her research focuses on cancer overdiagnosis, lung cancer screening, and health impacts of environmental factors. As first/corresponding authors, Dr. Li has published in several prestigious journals, such as BMJ, Lancet Diabetes Endocrinol, Gut, Nat Commun, Chest, BMC Med.
Ms. Ho Chiou Yi
Clinical Dietitian, National Cancer Institute
Ms Ho Chiou Yi is a highly respected clinical dietitian with 15 years of experience in medical nutrition therapy for surgery and oncology patients in government healthcare settings. Ms Ho boasts an impressive academic record. Her dedication to this specialized field is evident in her in-depth understanding of the unique nutritional challenges faced by individuals undergoing cancer treatment or surgery procedures. She is actively involved as part of the nutrition therapy team and her extensive experience allows her to create individualized nutrition care plans that optimize recovery and support overall well-being, especially perioperative medical nutrition therapy in the surgical gynaecologic, colorectal, and upper gastrointestinal cancer cases. This expertise makes her a valuable resource for healthcare professionals and patients alike. After graduating with a Bachelor Science of (Dietetics) at UKM, she continued her research focus with a Master’s in Clinical Nutrition (UPM), achieving a perfect CGPA and the Best Thesis Award. Currently pursuing a PhD, Ms Ho’s dedication to lifelong learning is undeniable. Her dedication to research is underscored by her publications in esteemed journals and numerous conference presentations. Notably, her passion for improving patient care through medical nutrition therapy has earned her prestigious accolades, such as the Dietetic Research Award and the Best Investigator Award which further solidify her reputation as one of the key figures in clinical nutrition research and patient care enhancement.
Prof. Edmund Sim Ui Hang
Professor,Universiti Malaysia Sarawak
Professor Dr. Edmund Sim Ui Hang is a distinguished academic at the Biotechnology Programme, Faculty of Resource Science and Technology, Universiti Malaysia Sarawak (UNIMAS). With a career spanning three decades, he began as a tutor in 1994 and advanced through the ranks to become a full Professor in 2019. A Genetics graduate from the University of Malaya, he earned his PhD from the University of Queensland in 2000. Professor Sim’s contributions to academia are profound, having developed Bioinformatics and Medical Biotechnology courses and taught extensively in Molecular Biology and Biotechnology. He has supervised 129 undergraduate and 29 postgraduate students, highlighting his commitment to mentorship. His research focuses on Cancer Genetics, particularly the molecular biology of nasopharyngeal cancer. Over 28 years, he has published 192 academic papers and led numerous funded research projects, garnering over RM 4.5 million in grants. His innovative work has earned him accolades like the Innovation Spotlight Award in 2024. Nationally, he serves on key committees, influencing research policies and education standards. His leadership roles at UNIMAS include Head of Molecular Biology Department, Deputy Dean, and university Senate committee member. Currently, he chairs the University Animal Ethics Committee and is the Chief Editor of the Scopus-indexed Borneo Journal of Resource Science and Technology.
Dr Luqman Mazlan
President,Asia-Pacific Federation of Coloproctology
Dr Luqman Mazlan is a Consultant Colorectal & General Surgeon and the Medical Director of PJ Integrated Cenrere of Advanced Surgey and Oncology (PICASO Hospital).
He is currently the President of the Asia-Pacific Federation of Coloproctology, Immediate Past President of the Malaysian Society of Colorectal Surgeons, Council Member, College of Surgeons Malaysia, a committee member of the European Society of Coloproctology Global Reach and Colorectal Cancer Survivorship Society of Malaysia
He was formerly the head of Colorectal Surgery and senior lecturer at the National University of Malaysia, Kuala Lumpur.
Dr Luqman has a special interest in recurrent and locally invasive colorectal cancers and minimally invasive colorectal surgery. He has multiple publications in peer reviewed journals and is involved in many international trials, research and educational activities related to colorectal surgery and clinical nutrition.
Ms Soo Sek Yow
Head of Nutrition Unit,Ace Canning Corporation Sdn Bhd
Ms Soo Sek Yow is the Head of Nutrition Unit at Ace Canning Corporation, a leading Malaysian beverage manufacturer, where she spearheads health and nutrition initiatives. Her role involves close collaboration with healthcare professionals, hospitals, academicians and scientific organizations. She also advises R&D and marketing teams to ensure product information and communication materials are aligned with current research.
Holding a BSc in Nutrition and Food Sciences from Utah State University, USA, Ms Soo actively participates in speaking engagements and is passionate about improving public health through evidence-based nutrition and debunking common myths surrounding food and nutrition.
Assoc. Prof Dr Nur Amani binti Ahmad Tajuddin
lecturer/ clinician,Universiti Malaya
Family Physician, Dr. Nur Amani holds a special interest in tobacco control activities. Dr. Nur Amani was awarded the WHO Hong Kong Tobacco Control Fellowship in 2015. She advocates for tobacco control and has carried out many community-based research projects to curtail tobacco use and its threat to public health. Dr. Nur Amani was formerly the lead person for the University for Society (U4S) Central Zone program, whereby the interventions for mental health were successfully integrated with those for tobacco control. Currently, she is the head of the Henti Elak Basmi Asap Tembakau (HEBAT) program. Dr. Nur Amani has written and co-written numerous peer-reviewed journal articles and books on tobacco control and related public health issues. She currently sits on the Scientific Committee to the WHO Framework Convention on Tobacco Control (FCTC) in Malaysia and was the expert panel member of the Parliamentary Select Committee in the development of the Tobacco Control Act. Dr. Nur Amani is still committed to pursuing evidence-based reforms for healthier communities.
Datin Dr Noraslinah Hj Ramlee
Consultant Physician,Jerudong Park Medical Centre
Datin Dr Noraslinah is a Consultant Physician and Head of the Early Detection & Cancer Prevention Services (EDCPS) at Jerudong Park Medical Centre (JPMC), Brunei. She holds a BSc in Medical Sciences from St Andrews University (1993), a medical degree from Manchester University (1996), and a Master’s in Family Medicine from Universiti Kebangsaan Malaysia (2008). She completed Observerships in cancer prevention at MD Anderson Cancer Centre and Mayo Clinic in 2018 and 2019. Before joining JPMC, she served in Brunei’s Ministry of Health as a Senior Medical Officer of Health. In 2019, she led the establishment of EDCPS, Brunei’s first cancer screening centre. The centre focuses on early detection, cancer education, and genetic screening support, and collaborates with the Ministry of Health on national screening programs. She is active in medical education and community health, serving on various committees. She is particularly passionate about health literacy and the prevention of non-communicable diseases.
Dr Ong Jue-Sheng
Team Head,QIMR Berghofer
Dr Jue-Sheng Ong is a data scientist and research entrepreneur with a PhD in Statistical Genetics from the University of Queensland, a Master of Mathematical Sciences from ANU, and an MBA focused on research commercialization. His work sits at the intersection of genomics, data science, research translation and digital health, with a strong emphasis on equitable precision medicine in under-represented populations.
Dr Ong leads the Global Precision Health Lab at QIMR Berghofer Medical Research Institute in Australia. He is the recipient of a prestigious NHMRC Investigator Grant and was awarded the 2023 QIMRB Postdoctoral Prize. He has contributed to large-scale gene-mapping efforts through international consortia, including the Esophageal Cancer Consortium and the International Genetics of Glaucoma Consortium, and has extensive experience in managing and designing biobank-based research.
His current work spans cancer, neurology, taste biology, and mental health. In Malaysia, he leads GLIMPSE-my—Malaysia’s first precision ophthalmology cohort—and is developing genetic studies on gastro-esophageal cancers and cardiometabolic conditions. In Australia, he is actively building frameworks to support research participation and engagement among culturally and linguistically diverse (CALD) and diasporic communities for precision medicine research.
Dr Ong currently serves as Team Head of the Global Precision Health Lab at QIMR Berghofer.
Prof. Dr Hamid Jan bin Jan Mohamed
Professor,Universiti Sains Malaysia
Professor Dr Hamid Jan Bin Jan Mohamed has been a professor at the Nutrition Programme, Universiti Sains Malaysia (USM) since 2007. He joined this institution immediately after completing his PhD (Nutrition) at King’s College London, United Kingdom.
At USM, he is the Deputy Dean of Research, Innovation and Industry-Community Engagement. He also works closely with the Ministry of Health Malaysia as a committee member of the Technical Working Group for Nutrition Guidelines (Children/Adults/Elderly) and other consultative activities. He is currently the Chairman of Technical Working Group (Nutrition Research) for the Ministry of Health Malaysia and is a Science Advisor of ILSI SEA Region. He is a Council Member of the Developmental Origin of Health and Disease Society (DOHaD). Currently, he is the Vice-President of the Nutrition Society of Malaysia. He is the recipient of the Top Research Scientists Malaysia Award 2024 by Academy of Sciences Malaysia.
Assoc. Prof. Dr. Mohd Razif Shahril
Associate Professor Dr,Universiti Kebangsaan Malaysia
Dr Shahril is an Associate Professor at Universiti Kebangsaan Malaysia and is involved in Nutritional Epidemiology and Public Health Nutrition research, specifically in non-communicable disease (including obesity) prevention and control works. He is actively involved in research related to obesity determinants and healthy ageing trajectories among cancer survivors with the support of local and international grants and collaborations. His expertise involves the use of digital technologies in tracking behaviour changes, dietary assessment and nutrition education and promotion. Dr Shahril works hand in hand with government agencies, NGOs, and industries to advocate healthy eating, cancer, and obesity prevention to the public. He has been trusted as a member of the Technical Working Group for Nutrition Research under the auspices of the Ministry of Health Malaysia and is involved in various works related to dietary guidelines revision for Malaysia. He is the Honorary Secretary of the Malaysian Association for the Study of Obesity (MASO) and a Life Member of Nutrition Society of Malaysia.
Dato' Fitjerald A/L Henry
Professor, Sunway University
Graduated from University Malaya in 1989. Obtained FRCS from University of Edinburgh.
Subsequently subspecialized in Colorectal Surgery.
Head of Surgical Department, Hospital Selayang from 2007-2019.
Appointed National Head of Colorectal Surgery services and Head of training committee from 2014-2022.
National Head of Perioperative Mortality review [POMR] 2020-2024.
Deputy Head of General Surgical services, Ministry of Health, Malaysia September 2021-April 2023.
Head of General Surgical services, Ministry of Health, Malaysia April 2023-September 2024.
Dr Shivaani Mariapun
Postdoctoral Researcher, Cancer Research Malaysia
Dr Shivaani Mariapun is a postdoctoral research scientist in the Cancer Prevention and Population Science (CPPS) research team at Cancer Research Malaysia (CRMY). She graduated from the University of Nottingham (UNM) with a PhD thesis focused on breast cancer epidemiology. She has worked closely with renowned breast cancer researchers, both locally and internationally, for over a decade to understand factors that influence disease susceptibility in Asian women. She is particularly interested in understanding common genetic variation associated with breast cancer risk and the utility of information from breast imaging data for risk prediction for women in our population. Her research leverages one of the largest and most comprehensive Asian cohorts with mammographic, epidemiological and genome-wide genetic data available, and has been published in leading breast cancer research journals. Her most recent publications have been on mammographic density, a strong and heritable risk factor for breast cancer.
Dr Malwinder Singh Sandhu
Consultant Clinical Oncologist, Pantai Hospital Kuala Lumpur
Dr. Malwinder Singh earned his Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) from Melaka Manipal Medical College in 2006 and later completed a Master of Clinical Oncology (M.Co) from the University of Malaya in 2015. He advanced his skills through specialized training in stereotactic radiotherapy (SBRT/SRS/SRT) at the prestigious Tata Memorial Hospital, Mumbai, and further refined his expertise in Gamma Knife Radiosurgery at Na Homolce Hospital, Prague, Czech Republic. His clinical practice is centered around advanced treatments, including Gamma Knife Radiosurgery for brain tumors and SBRT for prostate and lung cancers. With a special interest in breast, colon, lung, prostate, and brain cancers, he remains dedicated to providing cutting-edge, patient-centered care.
Dr Malwinder Singh Sandhu
Clinical Oncology, Pantai Hospital
Dr Malwinder Singh graduated from Melaka Manipal Medical College in 2006 with a Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) degree. He also obtained Master of Clinical Oncology (M.Co) in 2015 from University Malaya. He received his training in stereotactic radiotherapy (SBRT/SRS/SRT) at Tata Memorial Hospital in India and now specializes in Gamma Knife for brain tumours and SBRT for prostate and lung cancers. He has a special interest in breast, colon, lung, prostate and brain cancers. He has worked as an oncologist for the Ministry of Health at Hospital Sultan Ismail and Hospital Kuala Lumpur.
Prof. Dr Leong Chee-Onn
Chief Executive Officer, AGTC Genomics
Prof. Leong Chee-Onn is a distinguished cancer biologist with a rich career that spans both academia and genomics innovation. Before establishing AGTC Genomics, he held the position of Deputy Director of Research and Professor at the International Medical University.
He was a Senior Research Fellow at Harvard Medical School and Massachusetts General Hospital. As of now, he is a Fellow of the Institute of Biomedical Sciences (FIBMS, UK), Fellow of the Royal Society of Biology (FRBS, UK), and Fellow of the Royal Society of Chemistry (FRCS, UK).
Prof. Leong has served as an adjunct professor at Sunway University, Universiti Tunku Abdul Rahman, Universiti Malaya, and the University of Nottingham. His work, particularly focused on oncology and cancer biology, showcases his commitment to advancing healthcare through education and research.
Prof. Dr Anand Sachithanandan
Cardiothoracic Surgeon, Sunway Medical Centre
Prof Anand Sachithanandan is a consultant cardiothoracic surgeon to Sunway Medical Center & Subang Jaya Medical Center. He is the founding president of Lung Cancer Network Malaysia (LCNM), a disease-centric NGO dedicated to improving care and outcomes for lung cancer locally. He has championed and pioneered lung cancer screening in Malaysia including adoption of innovative AI-enhanced imaging and use of biomarkers. A strong advocate for multidisciplinary care, under his leadership LCNM has developed several national firsts to enhance lung cancer care including a digital patient navigation guide, a patient counselling tool for specialist doctors and clinical practice guidelines. Prof Anand is a clinical professor at the School of Medical & Life Sciences, Sunway University and adjunct professor in the Faculty of Medicine, University Malaya.
Dr Ang Boon Hong
Post-doctoral Scientist, Cancer Research Malaysia
Dr Ang Boon Hong is a statistician and epidemiologist in the Cancer Prevention and Population Science research unit at Cancer Research Malaysia. She earned her PhD in public health and biostatistics from Monash University Malaysia. Her current work focuses on breast cancer prevention and early detection, particularly among Asian populations. She leads population-level risk prediction efforts and has recently developed and refined the ARiCa risk calculator to help identify women who may benefit from genetic testing. Taking it a step further, her goal is to develop new or calibrate existing cancer risk models to inform individuals of their risk and guide effective, affordable screening strategies in low-resource settings through the lens of decision modelling. Building on this, she works closely with local and international experts to support data-driven approaches to cancer control, with a focus on population-level insights.
Dr Eliana Ahmad
Public Health Medicine Specialist, Ministry of Health Malaysia
Dr. Eliana binti Ahmad, MBBS, MPH, DrPH
Dr. Eliana binti Ahmad is a Public Health Medicine Specialist currently leading the National Cancer Control Programmes as well as Surveillance and Registry Unit for Non-Communicable Diseases (NCD) at the Ministry of Health Malaysia. With a Doctorate in Public Health from the University of Malaya, her work primarily focuses on cancer prevention and control, as well as the epidemiology of NCDs. Over her career, Dr. Eliana has played a pivotal role in shaping national strategies for disease prevention especially NCDs, including expanding cancer screening programs, Lung Health Initiative and managing public health responses to emerging health challenges.
She has contributed to research publications, particularly in addressing the growing burden of NCDs in Malaysia. Her leadership and commitment to public health continue to influence Malaysia’s health policies and systems.
Professor Ida Normiha Hilmi
Professor , University Malaya
Prof Ida Hilmi is a senior gastroenterologist at University Malaya. She is the President Elect of the Malaysian Society of Gastroenterology and Hepatology and her research interests include colorectal cancer screening.
Prof. Felicia Chung Fei Lei
Professor, Sunway University
Dr. Felicia Chung is a dedicated cancer cell biologist with a strong background in molecular biology and bioinformatics. Her research centers on cancer epigenetics and cancer cell biochemistry, supported by competitive research grants from agencies in Malaysia, Japan, and France. Dr. Chung has led and contributed to numerous high-impact studies on drug repurposing, immune evasion, epigenetics, metagenomics, and cancer signaling, with publications in leading journals such as Nature Communications, Nature Reviews Cancer, Environmental Health Perspectives, and Nucleic Acids Research. She currently serves as the Programme Leader for the BSc (Hons) Medical Biotechnology programme at Sunway University, where she is passionate about teaching and mentoring students. Beyond academia, Dr. Chung is actively involved in initiatives promoting early cancer screening and has contributed to research and community activities aimed at raising awareness and funds for cancer research. Her work reflects a deep commitment to both scientific advancement and public health.
Prof. Dr Cheong Sok Ching
Chief Scientific Officer, Cancer Research Malaysia
Professor Cheong is the Chief Scientific Officer at Cancer Research Malaysia and Adjunct Professor at the University of Malaya’s Faculty of Dentistry. Her research focuses on improving cancer patient outcomes, particularly for head and neck cancers, by studying molecular changes and developing innovative treatments like immunotherapy and CRISPR-Cas9-based approaches. She also advances early cancer detection through mobile health tools such as MeMoSA® for oral cancer. Her work is supported by prestigious grants, including those from the Newton Fund and Malaysia’s Ministry of Science. She has received multiple awards, including the IAOP President’s Award, the ASEAN-US Science Prize for Women, and the TWAS Medal Lecture.
A/Prof. Dr. Retnagowri Rajandram
Associate Professor , Universiti Malaya
Associate Professor Dr. Retnagowri Rajandram from Faculty of Medicine, Universiti Malaya is a pioneer academic scientist among surgeons in Malaysia, establishing their first laboratory. A BSc (Hon I) and PhD holder from University of Queensland Australia since age 25 with active collaboration as their Honorary Associate Professor. She is an advocate for cancer research including renal and colorectal cancers in form of publication and awareness campaigns including among the Orang Asli community. She has achieved several international and national awards from private and public institutions (e.g., 2017 UQ Alumni young distinguished award, the 2018 Malaysian Australian Alumni awards, The UM Excellence Award in 2019 and 2022. Retnagowri was part of the Steering Committee for the National Medical Postgraduate Training the Directors and Trainers for Malaysia between 2020 to 2024. She is also involved in educating Science-based Postgraduates, Malaysian Urologist, Cardiothoracic Surgeons and Oncologist.
Prof. Dr. Ho Gwo Fuang
Consultant Clinical Oncologist , Curie Oncology KL
Dr Ho Gwo Fuang is a clinical oncologist at Curie Oncology KL, Kuala Lumpur, Malaysia. He was trained at University of St Andrews and Manchester University 1992-1998; Royal Liverpool Hospital NHS Trust, Barts and The London NHS Trust and The Royal Marsden NHS Trust 1999-2007. He attained his Certificate for Completion of Specialist Training (CCST) in 2007 and joined the Faculty of Medicine at Universiti Malaya 2007. He was a Professor of Clinical Oncology and head of Master of Clinical Oncology training programme 2021-2023. He was appointed Adjunct Professor in the Department of Radiation Oncology, Manipal Academy of Higher Education, Mangalore, India and M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tungku Abdul Rahman, Malaysia 2024. His research interests involve breast, gastrointestinal, and hepatobiliary cancers. He co-authored the Pan-Asian Adapted ESMO Clinical Practice Guidelines for hepatocellular carcinoma (2020) and ASCO Resource Stratified Guideline for Early Detection for Colorectal Cancer (2019) and Treatment of Patients with Early-Stage Colorectal Cancer Resource Stratified Guideline (2019). He is involved in many national and international collaborative research work, as well as the training of new oncologists in Malaysia.
Dr Tan Chih Kiang
Consultant Clinical Oncologist, Picaso Hospital
Dr. Tan Chih Kiang is a consultant clinical oncologist at Picaso Hospital, Malaysia, with a strong commitment to improving cancer care. He holds an MBBS and a Master’s in Clinical Oncology from University Malaya.
As the Honorary Secretary of the Malaysian Oncological Society, Dr. Tan works closely with peers to advance oncology education and research. He has contributed as a co-author to international clinical guidelines and participated in numerous clinical trials, taking on roles as both a principal investigator and sub-investigator. He also provides his expertise as an external reviewer for international medical journals.
Dr. Tan played a key role in establishing stereotactic radiosurgery (SRS) services in East Malaysia, where he treated the first SRS patient in Sarawak. His clinical interests span gastrointestinal cancers, with a focus on liver cancer, as well as breast, gastrointestinal cancer and head and neck cancer
Dr Nur Fadhlina Abdul Satar
Consultant Oncologist, Pantai Hospital Kuala Lumpur
Dr. Fadhlina, fondly known as Dr. Nina, is a consultant oncologist at Pantai Hospital Kuala Lumpur. She was a senior lecturer at University Malaya’s Clinical Oncology Department, earning the Excellence Service Award in 2023. Trained at University College London and Barts NHS Trusts, UK, she holds a Master’s in Clinical Oncology. Passionate about medical education, she contributes to Cancer ECHO UM project and is principal investigator on international clinical trials. Notably, she won the highest research grant procured by University Malaya Medical Centre in 2021. In 2023, she won the Japan Society in Medical Oncology Rising Star in Asia Workshop in Japan. Dr. Nina actively publishes research and speaks at public forums on cancer awareness.
Dr Beverley Lim Hoeg
Psychologist and Researcher, Danish Cancer Institute
I am a psychologist and researcher with a focus on the psychosocial impact of being a cancer patient and family caregiver. I use a broad range of methodologies including research based on registry data, self-reported questionnaires, qualitative interviews and systematic reviews/meta-analysis.
Mrs Betti Sharina binti Mohd Haniff Lai
Clinical Dietitian, Institut Kanser Negara
A compassionate Clinical Dietitian with over 10 years of experience, specializing in oncology nutrition, with main interest in Head and Neck cancer. Graduating with a Bachelor of Science in Dietetics from Universiti Putra Malaysia in 2009, I have worked at Hospital Sultanah Nur Zahirah, Kuala Terengganu and Institut Kanser Negara, Putrajaya. With a strong background in clinical audits, research, and innovation projects, I am committed to providing evidence-based and individualized dietary management to cancer patients. In 2022, I was recognized as Runner-Up in Clinical Audit and Second Runner-Up for Research Poster at the Allied Health Scientific Conference in 2023. Regularly provide health talks to healthcare staff and the public on nutrition and its importance in disease prevention and management, particularly cancer-related nutrition. My career goal is to provide continuous, updated nutrition care to cancer patients, respecting their unique backgrounds and beliefs.
Dr Hadi Mohamad Abu Rasheed
Scientific Advisor, Head of the Professional Development and Research Department, Qatar Cancer Society
Dr Hadi is the Scientific Advisor and the Head of the Professional Development and Scientific Research Department and the Qatar Cancer Society (QCS). Dr Hadi is the representative member of the QCS in the National Cancer Governance Board in Qatar, the Gulf Federation for Cancer Control, the Union International for Cancer Control, the World Cancer Day Advisory Group, the World Ovarian Cancer Coalition, and the All.Can International. He is also an Adjunct Lecturer at the College of Health Sciences at The University of Doha for Science and Technology, preceptor at the Department of Public Health – College of Health Sciences – Qatar University, Psychology and Social Work Master’s Program at the Doha Institute for Graduate Studies, and Hamad Medical Corporation community medicine residency program. Dr Hadi graduated from the University of Aleppo – Faculty of Medicine in Syria and completed his post-graduate training at the University of Iowa in the USA. Dr Hadi presented at more than 100 medical conferences and was involved as a Co-PI in research projects that have earnt grants of around half a million dollars in the USA and Qatar. Dr Hadi’s research interests are pediatric diseases, cancer burden, cancer education and awareness, continuing medical education, Knowledge Attitudes Perception studies related to cancer, quality of life of people living with cancer, health literacy, cancer survival studies, equity in cancer care, narrative medicine and cancer, palliative care, the role of civil societies in cancer control, social media and cancer awareness, and efficiency and efficacy in cancer control and public health.
Ms. Ishtar Espejo Castellá
Executive Director, Fundación Aladina
Ishtar Espejo Castellá.
Born in Madrid, Ishtar earned a Law degree and completed postgraduate studies in European Union Legal and Economic Studies in Paris. She has led Fundación Aladina for over 19 years, helping shape it into Spain’s leading organization supporting children with cancer and their families. Under her leadership, Aladina is present in 22 hospitals, has completed more than 60 pediatric renovation projects, and supports over 2,000 families annually through comprehensive emotional, psychological, and material care. She remains personally involved, regularly visiting hospitals and staying close to families and care teams. Ishtar has built strong partnerships with medical institutions, international organizations, and corporate allies, and developed innovative fundraising strategies and nonprofit models. Aladina is the first Spanish member of St. Jude Global and an active participant in Childhood Cancer International (CCI). In 2019, she was named a UICC Young Leader Against Cancer, and in 2025, was a finalist in the “Top 100 Women Leaders in Spain” under Public Service and Social Action.
Prof Kenneth Kwing-Chin Lee
Professor of Health Economics, Monash University Malaysia
Health economics focuses on how to make healthcare more accessible, affordable, equitable and sustainable. Health economists research into the factors that influence the provider’s costs and the recipient’s change in quality of life and the willingness-to-pay from both a payor and a societal perspective. Kenneth Lee’s research area is focused on both micro and macro levels of health economics with the intention of generating unbiased real-world evidence for the best decision-making in healthcare policy. He has more than 30 years of teaching and research experience in this area with more than 120 publications in international peer-reviewed journals. He is one of the few health economists in Asia who have an international reputation and network. He is the Editor-in-Chief of 2 main international journals of health economics. Locally, he has served in a number of advisory committees for the Ministry of Health and MITI.
Dr Melissa Lim Siaw Han
Doctor of Philosophy, UNIMAS
Melissa, a lecturer at Universiti Malaysia Sarawak (UNIMAS) since 2022, holds a Pharmacy degree from the University of South Australia (UniSA) and a PhD in Medical Science (Pharmaceutical Nanotechnology) from Okayama University, Japan, under prestigious Malaysian and Japanese scholarships. She is a Union for International Cancer Control (UICC) Young Leader (2021/2022) and recipient of the 2024 Prof. Yoo Hang Kim Young Women Scientist Award. With 13 years of clinical pharmacy experience, Melissa specializes in theranostics, pharmacogenetics, and women’s cancers. She co-founded the Society for Cancer Advocacy and Awareness Kuching (SCAN) and actively contributes to cancer and women’s NGOs. Since 2012, she has led breast cancer outreach programs across rural Sarawak, reaching over 40 villages and 30 ethnic groups. Melissa is also a member of MASCC, ESMO, and MPS, with extensive experience in Industry Sponsored and Investigator Initiated Research. She currently leads multiple national and industry-funded grants on women’s cancer.
Prof Yap Lee Fah
Professor, Universiti Malaya
Prof Yap obtained her PhD from the University of Bristol, UK, and returned to Malaysia as a Principal Investigator focusing on nasopharyngeal carcinoma (NPC). She received a UICC American Cancer Society fellowship to work at the University of Birmingham, UK, before joining Universiti Malaya in 2012. As a leading NPC researcher in Malaysia, her work explores the molecular pathogenesis of NPC and the role of Epstein-Barr virus (EBV) in its development. She has identified several oncogenes and tumour suppressor genes, and elucidated how EBV influences NPC gene expression. Prof Yap has published in top cancer journals such as Journal of Pathology, Oncogene, and Nature Reviews Cancer. She has received various national and international research grants as well as research awards. Prof Yap co-founded the NPC Society of Malaysia and currently serves as its President. She was recently appointed by the Ministry of Health as taskforce leader for the NPC expert group in the upcoming National Strategic Plan for Cancer Control (NSPCC).
Prof Goh Bey Hing
Professor & Head of Sunway Biofunctional Molecules Discovery Centre (SBMDC), Sunway University
Professor Ts Dr Goh Bey Hing leads the Sunway Biofunctional Molecules Discovery Centre (SBMDC), Faculty of Medical & Life Sciences, Sunway University, focusing on the biofunctionality and pharmacological applications of diverse molecules. His extensive research spans fundamental science and collaborations with industry and healthcare. Internationally, he is the first Malaysian on The Advisory Board of The International Natural Product Sciences Taskforce (INPST) and holds the distinction of Chartered Biologist (Royal Society of Biology, UK). Professor Goh has received Malaysia’s Research Star Award by the Ministry of Education Malaysia, was named among the Top 10 Outstanding Young Malaysians by Junior Chamber International and is a Top Research Scientist Malaysia by the Academy Sciences Malaysia in recognition of his significant contributions to research, education, and community.
Prof Dr Mai Chun Wai
Professor, Institute for Research, Development and Innovation (IRDI), IMU University
Prof. Dr. Mai Chun Wai is a Professor and Head of the Centre for Cancer and Stem Cell Research at the Institute for Research, Development and Innovation (IRDI), IMU University, Malaysia. He is a fully registered pharmacist with the Pharmacy Board of Malaysia and a Chartered Scientist accredited by the Royal Society of Chemistry (UK). He currently serves as Chairperson of the Young Scientists Network–Academy of Sciences Malaysia (YSN-ASM), where he actively promotes scientific integrity, research excellence, and talent development. He also holds the position of Deputy Chairperson for the International Pharmaceutical Federation (FIP)–UNESCO University Twinning and Networking (UNITWIN) programme for the Western Pacific region. His research applies multiomic approaches to investigate cellular and cancer biology, with a focus on rational drug design and translational applications. Prof. Mai has published extensively and contributes significantly to advancing biomedical research, both locally and globally, particularly in the fields of cancer biology and drug discovery.
Dr Voon Pei Jye
Consultant Medical Oncologist, Hospital Umum Sarawak (Sarawak General Hospital)
Dr Voon Pei Jye is the Head and Consultant Medical Oncologist, Department of Radiotherapy and Oncology, Hospital Umum Sarawak (Sarawak General Hospital). He is also an Adjunct Professor Universiti Malaysia Sarawak (UNIMAS).
He read medicine at UNIMAS. He subsequently obtained his MRCP (United Kingdom) and Master of Medicine (Internal Medicine) from National University of Singapore. Thereafter, he received his advanced specialist training in Medical Oncology from National University Hospital Singapore. He has also completed his Phase 1 Drug Development clinical research fellowship at Princess Margaret Cancer Centre, University of Toronto, Canada.
He is an active investigator for numerous cancer trials encompassing early phase through to late phase studies. He has keen interest in oncology development therapeutic and thoracic oncology. Dr Voon has published in various peer reviewed journals. He is a recipient for Hold’em for Life Oncology Fellowship Award, University of Toronto. He has also won the Scholar Training Award from AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021.
Ms. Harpreet Kaur A/P Darshan Singh
Executive Director, Malaysian Pharmacists Society
Harpreet Kaur is a highly experienced pharmacist with a Bachelor of Pharmacy from Universiti Sains Malaysia (2004) and various certifications, including Good Clinical Practice. She has served in multiple leadership roles within the Malaysian Pharmacists Society (MPS) in the past 10 years and is currently the Executive Director. Harpreet has a rich background in both industry and healthcare settings, including regulatory affairs, pharmacovigilance, and quality assurance roles at notable generic and multinational companies Her career also emphasizes significant contributions to community pharmacy and numerous committee involvements focused on improving pharmacy practice and healthcare delivery Drawing from her experience in Malaysian Pharmacists Society, hospital, community, industry, and healthcare policy, Harpreet will share how professional organisations can influence healthcare delivery beyond clinical settings — by empowering communities, supporting cancer care initiatives, and driving meaningful change in Malaysia’s health ecosystem.
Dr Vijayan Munusamy
Clinical Specialist, University Malaya Medical Centre
Dr. Vijayan Munusamy is a highly accomplished Consultant Physician and Respiratory Specialist with a strong focus on research, clinical teaching, and the management of complex pulmonary diseases. His expertise spans airway diseases, pleural interventions, and interventional pulmonology, supported by advanced training including a Master’s in Respiratory Medicine from the University of South Wales, UK. Dr. Munusamy possesses a broad skillset covering conditions such as asthma, COPD, lung cancer, and tuberculosis, along with specialized proficiencies in bronchoscopy, thoracic ultrasound. He is an active member of prestigious societies like the Malaysian Thoracic Society and the European Respiratory Society, reflecting his commitment to the field.
In addition to his clinical work, Dr. Munusamy is deeply involved in research, with numerous publications on topics ranging from COVID-19 genomics to eosinophilic asthma therapies. He has contributed to public health initiatives, including advisory roles in Malaysias COVID-19 vaccination program and cancer awareness projects. His academic contributions include co-authoring booklets on psychosocial support for cancer patients and universal healthcare coverage for NCDs. Currently, he is engaged in ongoing clinical trials underscoring his dedication to advancing respiratory medicine. Awards like the Anugerah Kakitangan Cermerlang 2012 and scholarships from the Merck Foundation further highlight his professional excellence
Dr Teh Kok Hoi
Pediatric Hemato-Oncologist, Hospital Kuala Lumpur
Dr Teh Kok Hoi is a Paediatric Haematologist & Oncologist at the Paediatric Department of Hospital Tunku Azizah, Kuala Lumpur. He graduated from University of Malaya with a distinction in his MBBS degree and was awarded bronze medallion of the King Edward VII College of Medicine Alumni Association. He received his post-graduation MRCPCH (UK) certificate in Paediatrics before completing his subspecialty training in Paediatric Haematology & Oncology in Birmingham’s Children Hospital, United Kingdom. Dr Teh is passionate in childhood solid tumour and Langerhan’s Cell Histiocytosis. He is a member of the Technical Expert Working Group for Childhood Cancer of the Ministry of Health, a trainer for Paediatric Haematology and Oncology subspecialty fellowship program, an Educational Supervisor for Malaysian Paediatric Postgraduate training program and guest lecturer for Post-Basic Nursing Diploma in Paediatrics and Oncology. Dr Teh has been invited as a speaker at national and international oncology conferences. He has appeared at various mass media including radio, TV, Tik Tok, Facebook, and newspapers and in various languages to increase public awareness about childhood cancer.
Apart from his dedication to clinical service, he also participates actively in clinical research and has more than 80 publications to date. His guided presentations have won the top three prizes at poster presentations of MASPHO’s annual scientific meetings every year since 2017. His team was winner of Strategic Innovative Project category at National QA Convention of the Ministry of Health in 2024.
He was elected President of Malaysian Society of Paediatric Haematology & Oncology (MASPHO) for the last 4 terms since 2021. He is also an exco member of Persatuan Kebajikan Kanser Kanak-Kanak (PEKA).
Dr Vijayan Munusamy
Clinical Specialist, University Malaya Medical Centre
Dr. Vijayan Munusamy is a highly accomplished Consultant Physician and Respiratory Specialist with a strong focus on research, clinical teaching, and the management of complex pulmonary diseases. His expertise spans airway diseases, pleural interventions, and interventional pulmonology, supported by advanced training including a Master’s in Respiratory Medicine from the University of South Wales, UK. Dr. Munusamy possesses a broad skillset covering conditions such as asthma, COPD, lung cancer, and tuberculosis, along with specialized proficiencies in bronchoscopy, thoracic ultrasound. He is an active member of prestigious societies like the Malaysian Thoracic Society and the European Respiratory Society, reflecting his commitment to the field.
In addition to his clinical work, Dr. Munusamy is deeply involved in research, with numerous publications on topics ranging from COVID-19 genomics to eosinophilic asthma therapies. He has contributed to public health initiatives, including advisory roles in Malaysias COVID-19 vaccination program and cancer awareness projects. His academic contributions include co-authoring booklets on psychosocial support for cancer patients and universal healthcare coverage for NCDs. Currently, he is engaged in ongoing clinical trials underscoring his dedication to advancing respiratory medicine. Awards like the Anugerah Kakitangan Cermerlang 2012 and scholarships from the Merck Foundation further highlight his professional excellence
Dr Arnil George Sirimanne
Doctor, Prince Court Medical Centre
Dr Arnil Sirimanne completed his undergraduate studies at Penang Medical College and got his MB BCh BAO (Ireland) degree in 2002. He completed his Master of Clinical Oncology at Universiti Malaya in 2017 and served as a Clinical Oncologist at Hospital Umum Sarawak and Institut Kanser Negara until late 2021. His current interests are stereotactic radiosurgery of the brain, head & neck and urological malignancies. Currently, he is practising as a Consultant Clinical Oncologist at Prince Court Medical Centre in Kuala Lumpur.
Prof Vetriselvan Subramaniyan
Professor and Deputy Dean of Internationalisation, Sir Jeffrey Cheah Sunway Medical School, Faculty of Medical and Life Sciences, Sunway University
Dr. Vetriselvan graduated from Annamalai University in India. His academic career started in 2008 at Rajiv Gandhi University of Health Sciences, Bangalore and have more than fourteen years of teaching and research experience at several universities including the School of Medicine at Arba Minch University, Ethiopia (UNDP program) and the Faculty of Medicine, Bioscience and Nursing, Malaysia. During his Master’s study, he received a sponsored research project from the Natural Remedies Research Centre, Bangalore, in 2007. He has filed eight patents in different countries, including India, Germany, Australia, and South Africa. Moreover, he also published over 135 papers with a cumulative impact factor of 375 plus and published five book chapters. Dr. Vetriselvan also received an internal and external pilot grant in 2021 and 2022. His research interests include synthetic and phyto-based drug development and pharmacological screening (in silico, in vitro, and in vivo) of cancer and metabolic diseases. He is one of the editorial board members of the Journal of Pharmacological Research. He has secured both internal and external grants for his research. Furthermore, he currently supervises Ph.D. and master’s students. He has been a keynote and invited speaker for over 23 conferences. He is associated with Saveetha Medical College, Sree Balaji Medical College, and Sri Lakshmi Narayana Institute of Medical Science India as an Adjunct Professor. Moreover, he is a member of the Malaysian Society of Pharmacology and Physiology (MSPP), a Fellow of the Malaysian Scientific Association (MSA), and an executive member of the Indian Pharmacological Society.
Dr Anas Nofal
Chief Business Officer, Axios International
Dr Anas Nofal, Chief Business Officer of Axios International since 2011, has significantly expanded the company’s presence globally through his leadership and expertise. He is a well-rounded healthcare professional with experience in clinical practice, program design, implementation, and compliance. Dr Anas is passionate about providing access to quality healthcare services, reducing healthcare inequalities, and addressing patient needs through innovative and sustainable solutions. Dr Anas oversees strategic planning, business development, project implementation, and relationships for all Axios’ healthcare access programs with stakeholders including charity organizations, the pharmaceutical and insurance industries, healthcare providers, regulators, medical associations, and more. He has successfully established unique and sustainable strategies to access patient support programs and fostered public-private partnerships. Dr Anas holds a Ph.D. in Public Health and a master’s degree in business administration, and a Bachelor of Science. He is fluent in English and Arabic
Dr Rahul Kapur
Vice President and Head of Medical Affairs, Biocon Biologics
Dr Rahul Kapur heads Medical Affairs across Global, Emerging markets and European teams at Biocon Biologics. Rahul is an experienced medical leader with a strong background across global and affiliate organizations. He brings deep scientific expertise across multiple therapeutic areas. He has previously held key roles at Vifor Pharma and Novo Nordisk across Europe, leading medical affairs, regulatory, safety and clinical operations. He started his career working in early R&D on novel drug discovery programs before moving to medical affairs at Novo Nordisk where he was responsible for the medical launch of several key products globally an. In his current role, Rahul oversees medical affairs operations, providing strategic direction and support to ensure the successful implementation of medical programs. Rahul trained as a doctor at the St Johns Medical College in Bangalore, and he also holds a PhD in regenerative medicine and drug discovery from Copenhagen University. He has published extensively with multiple abstracts and papers mainly in the metabolic disease space.
Dr Akhmal Yusof
Chief Executive Officer, Clinical Research Malaysia
Dr Akhmal Yusof graduated from the Royal College of Surgeons in Ireland in 1992. He practiced medicine in the public & private hospital for nearly 10 years. He later ventured in the medical insurance industry with the American International Assurance Malaysia as Medical Manager. Later in 2002, he led the Medical Department in AstraZeneca Malaysia, Singapore & Brunei for 13 years. His main forte in the pharmaceutical industry is clinical research management, regulatory affairs, medical and government affairs. Currently he leads Clinical Research Malaysia (CRM) as Chief Executive Officer since 2015. CRM is a Malaysia Ministry of Health owned Site Management Organisation. Established in 2012 to promote Sponsored Research in Malaysia. CRM is now accredited ISO9001:2016 and ISO37001:2015. Under the CRM Phase 1 Realisation Project (P1RP), Malaysia has started to expand into First in Human Clinical Trials. Dr Akhmal Yusof is also a member Board of Trustee and Chairman Nominating & Remuneration Committee for the National Institute of Biotechnology Malaysia.
Prof. Dr Chin Kin Fah
Chairman and Founding Director, Academy of Silent Mentor
Professor Dr. Chin Kin Fah is a distinguished laparoscopic surgeon based in Malaysia, known for his expertise in minimally invasive laparo-endoscopic surgery, surgical oncology, gastrointestinal surgery, bariatric and metabolic surgery, and clinical nutrition. He practices at prestigious hospitals, including Gleneagles Hospital, Kuala Lumpur, and others.
A University of Aberdeen alumnus, he completed his specialist training in the UK, followed by significant roles in Australia and the NHS before returning to Malaysia. As an educator, he has served as a dean at Taylor’s University and now holds professorial roles at UTAR and other institutions.
Prof. Dr. Chin is the founder of the Silent Mentor Programme, aiming to advance medical education and research by encouraging body donation. He also established the Academy for Silent Mentor and a Rapid Tissue Donation Programme for cancer research. His contributions are recognised globally, with multiple publications and leadership roles in various medical societies.
Dr Kong Li Ren
Assistant Professor of Cancer and Stem Cell Biology, Cancer Discovery and Regenerative Medicine Programme , Lee Kong Chian School of Medicine, Nanyang Technological University
Li Ren Kong received his Ph.D. in Cancer Pharmacology from the National University of Singapore, where he studied resistance mechanisms in chemo-refractory tumours. He completed postdoctoral training at the Cancer Science Institute of Singapore, focusing on profiling cancer-specific phenotypes to guide targeted drug repurposing and improve patient outcomes. As part of the joint NUHS-Cambridge initiative, he furthered his training at the MRC Cancer Unit, University of Cambridge. In 2022, Li Ren was awarded the prestigious Lee Kuan Yew Fellowship and returned to Singapore to investigate the cell-autonomous functions of population-specific, cancer-associated germline mutations, with the goal of informing precision cancer therapies. He is currently an Assistant Professor at the Lee Kong Chian School of Medicine, where his laboratory focuses on understanding how inter-tumour dynamics drive cancer progression. By integrating advanced omics technologies with conventional molecular approaches, his work aims to improve early diagnosis and intervention strategies for cancers prevalent in Asian populations. Li Ren’s research is supported by the Ministry of Education, the National Medical Research Council, and the NUSMed Translational Research Programme. He has published extensively in leading scientific and clinical journals, including Cell, Nature Communications, Lancet Oncology, and Annals of Oncology, with his findings contributing to biomarker-driven clinical trials.
Dr Saiful Adni bin Abd Latif
Doctor, Institut Kanser Negara
Dr. Saiful Adni Abd Latif completed his undergraduate medical degree from University of Leicester, United Kingdom in 2009. He has served various hospitals under the Ministry of Health, Malaysia as a medical officer and Internal Medicine Specialist before pursuing subspecialty training in Palliative Medicine. Currently, he is working in National Cancer Institute Putrajaya. He is also involved in several non-governmental organizations (NGO), namely the Malaysian Hospice and Palliative Care Council (MHPCC) and Hospis Melaka. His areas of interest are psychosocial aspects in coping with life-limiting illness and advocacy for the field of palliative care.
Dr Kenneth Voon KherTi
Consultant Colorectal Surgeon, Sarawak General Hospital
Obtained CCT for Colorectal Surgery in 2021. Head of Colorectal Surgery Unit, Sarawak General Hospital from 2021 till 2024, then Head of Colorectal Surgery & Head of Endoscopy Unit, Miri Hospital from Nov 2024 till now.
Other portfolios:
Trainer for General Surgery Residency Candidates
Principle Investigator for several clinical trials
Visiting consultant to various hospitals in Sarawak
Advocates & Coordinates Colorectal Cancer Screening Programmes locally, while act as medical advisor for local cancer survivorship movements.
Special Interest: Advanced Malignancy Surgery, Anorectal Surgery particularly Anorectal Fistula.
Assoc. Prof Dr Mohd Faizal Ahmad
Clinical Specialist & Lecturer of Obstetrician & Gynaecology, Hospital Canselor Tuanku Mukhriz Universiti Kebangsaan Malaysia (HCTM UKM)
Dr. Mohd Faizal Bin Ahmad is a clinical specialist and lecturer of Obstetrician & Gynaecology in Hospital Canselor Tuanku Mukhriz Universiti Kebangsaan Malaysia (HCTM UKM), specializing in Reproductive Endocrinology & Oncofertility. He currently serves as one of the reproductive specialists in Advanced Reproductive Center (ARC) HCTM UKM. In addition to reproductive medicine, he is also interested in the oncofertility field. In 2019, he initiated the oncofertility services under ARC by managing fertility preservation (FP) for oncology cases. Subsequently, he received Takeda Science Foundation Award to pursue his oncofertility fellowship under St Marianna School of Medicine Hospital, Kanagawa, Japan. His training is mainly in the cryobiology field; In-vitro Maturation (IVM), and Ovarian Tissue Cryopreservation (OTC). He obtained the credentialing in IVM & OTC and currently initiated these services under ARC as oncofertility services. He also initiates testicular tissue cryopreservation (TTC) for pre-pubertal research using the mice model under the supervision of Prof Nao Suzuki during his fellowship attachment in Japan. He currently serves as Vice President of Malaysian Society of Fertility Preservation (MSFP) and as Board Member of Asian Society of Fertility Preservation (ASFP) representing Malaysia. He has conducted research, published several papers in reproductive medicine and oncofertility, and presented in national and international congresses. His latest research is mainly on endometriosis – elucidating HOXA 10 expression following GnRH modulator and In-Vitro Maturation Oocytes Quality Assessment via Gene Expression (PTS2, GREM) supported by KPT Research Grant Ministry of Education
Dr Nur Nadiatul Asyikin binti Bujang
Dr, Pejabat Kesihatan Lembah Pantai
I graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Malaya in 2011 and completed my housemanship at Hospital Sultan Abdul Halim, Kedah. I later served as a medical officer at Klinik Kesihatan Ibu dan Anak (KKIA) Kg Pandan Dalam and the Hulu Langat District Health Office, Selangor. In 2019, I obtained my Master of Public Health (MPH) with distinction from the University of Malaya, followed by completing my Doctor of Public Health (DrPH), funded by the Ministry of Health Malaysia. I am currently a Public Health Specialist in Kuala Lumpur and serve as the Secretary of Colorectal Cancer Survivorship Malaysia (CORUM). My research focuses on colorectal cancer, cancer beliefs, epidemiology, and public health interventions. I have published articles in JAMA Oncology, JCO Global Oncology, and WPSAR, and I actively contribute as a peer reviewer and writer in the field of public health.
Dr. Lim Ren Jye
A. Professor, Sunway TCM Centre
A. Prof. Dr. Lim Ren Jye is a dual-licensed medical professional, among the few in Malaysia qualified in both conventional and traditional Chinese medicine. He is the Medical Director and Integrative Medicine Consultant at Sunway TCM Centre, Sunway Healthcare Group, with extensive experience in integrative cancer care. Dr. Lim has trained and practiced in Malaysia and China, including at Seremban General Hospital, the National Cancer Institute, and Shanghai Longhua Hospital. He actively bridges conventional and traditional medicine, serving as a Visiting Associate Professor at Shanghai University of TCM and a lecturer at UiTM and IMU. His team has earned recognition at the National Cancer Forum and published multiple SCI-indexed papers. A medical columnist and bestselling author of *Hey! Doctor Speaks Human*, Dr. Lim is also a key advocate for TCM policy reforms, successfully lobbying for tax exemptions on TCM treatments to improve accessibility and integration into Malaysia’s healthcare system.
Ms Tan Jie Sin
Dietitian, Sunway Medical Center
Tan Jie Sin received her credential in Bachelor of Science Degree in Dietetics from University Putra Malaysia. She is currently an active member of Malaysian Dietitians’ Association (MDA). Jie Sin started her career as a clinical dietitian in a government hospital in Klang. She then joined a private hospital in Klang Valley prior joining Sunway Medical Centre, working across different disciplines. She is a practicing dietitian who involves in providing diet counselling, medical nutrition therapy and nutrition support for patients with different diseases. She conducts health talks to corporate and public, executes educational programs for food services staffs and nurses She also involved in writing health e-newsletter. She has strong interests in managing patients in critical care, obesity and cancer.
Dr Gogillan Sevaratnam
Chair for Scientific Committee on Occupational Medicine, ICOH, Chair for Scientific Committee on Occupational Medicine, ICOH
An Occupational Physician with more than 23 years of experience in health, of which 16 years’ experience in the field of Occupational Health. Upon completion of Masters in Public Health (MPH), joined Department of Occupational Safety and Health (DOSH) under Ministry of Human Resources as Occupational Physician for 2 years. In 2012, completed Membership of the Faculty of Occupational Medicine (MFOM), Ireland. In 2014, received a Fellow of Institute of Medical Sciences (FIAMS) for Occupational Medicine, India. Actively involved in conducting occupational health trainings for workers in various industries. A qualified trainer in Occupational Health and a visiting lecturer for National Institute of Occupational Safety & Health (NIOSH, Malaysia). Visiting Lecturer for Kathmandu Medical College, Nepal
Other major involvements:
1. Chair for Scientific Committee on Occupational Medicine (SCOM), International Commission on Occupational Health (ICOH)
2. Vice-President for Malaysian Society of Occupational Health Doctors (MSOHD)
Prof Dr Nirmala Bhoo Pathy
Professor , Universiti Malaya
Nirmala Bhoo Pathy is a professor of epidemiology, and a board-certified public health physician at University Malaya Medical Centre in Malaysia. With a career focused on improving access to cancer care and optimizing life after cancer, she is a champion for enhancing cancer health systems, particularly in low- and middle-income countries. Prof. Bhoo Pathy has been instrumental in leading landmark studies like the ACTION study, which provided crucial evidence for policy changes across Southeast Asia. She has served as a commissioner on the Lancet Commission on Women, Power, and Cancer, and leads the economic section of the Lancet Oncology Commission on Cancer as a Human Crisis.
Dr Abd Razak Muhamad
President, Max Family Society Malaysia
Co-founder of Max Family Society Malaysia 2006, President and Advocates since 2006, Leading a local patient support group for people living with CML (Chronic Myeloid Leukemia), Focusing on empowering patients and caregiver on disease education and advocating living lives as CML through series of patients meeting and workshop through out the country and raising awareness on CML and blood cancers. Personally, I am also diagnosed with CML in 2006 and survived stem cell transplant 2007
Professionally work as Pediatric Orthopedics Surgeon at Gleneagles Kuala Lumpur
Associate Professor Dr. Caryn Mei Hsien Chan
Associate Professor , Universiti Kebangsaan Malaysia
Caryn Mei Hsien Chan is an Associate Professor and Consultant Psychologist at Universiti Kebangsaan Malaysia, specializing in psychology and behaviour change strategies for preventing non-communicable diseases, particularly tobacco and cancer control. She advises the Malaysian government and global initiatives on national health policy and guidelines. She serves as a WHO Technical Advisory Group member for Behavioural Sciences, and on the technical committee and working group for Malaysia’s WHO Framework Convention on Tobacco Control and National Strategic Plan for Non-Communicable Diseases. Prof. Chan is an executive board member of Malaysia’s Medical Research & Ethics Committee and a Deputy Chair of UKM’s Research Ethics Committee. With over 100 peer-reviewed publications, she actively mentors researchers and contributes to public health initiatives across Southeast Asia.
Dr Mark Cheong Wing Loong
Deputy Head of School (Education), School of Pharmacy, Monash University Malaysia
Dr Mark Cheong Wing Loong is a public health and palliative care researcher at the School of Pharmacy, Monash University Malaysia. His work focuses on building better, kinder, and more accessible health systems and healthcare services, as well as how adopting a palliative and supportive care lens can improve healthcare for all. Dr Cheong also studies the lived experiences of people who interact with, use, or work in healthcare systems, as well as unmet needs of people living with complex life-limiting illnesses. Dr Cheong has been a collaborator and consultant with organizations including the World Health Organization (WHO), the Drugs for Neglected Diseases initiative (DNDi), Ministry of Health Malaysia, and the Third World Network on health advocacy projects on palliative care, access to medicines and healthcare, and health inequalities.
Dr Cheong is currently a Visiting Fellow at the United Nations University – International Institute for Global Health, Visiting Scholar at the Maybank ASEAN Research Center at the Asia School of Business, and a Fellow of the Royal Society for Public Health (FRSPH, UK). He is also a member of the National Palliative Care Services Development Committee, Ministry of Health Malaysia.
Mrs Hoo Yee Yin
PhD Student, Department of social and preventive medicine University Malaya
I was a clinical pharmacist at a government hospital under the Ministry of Health, Malaysia, for 15 years. Currently, I am pursuing my PhD at the Social and Preventive Medicine Department, University Malaya, focusing on Comorbidities and Unmet Supportive Care Needs in Individuals with Cancer, with a special interest in cardiovascular comorbidities in this population.
Mr Abdullahi Sheriff
Managing Director, MSD Singapore, Malaysia & Brune
Dr Abdullahi Sheriff is the Managing Director for MSD in Singapore, Malaysia & Brunei, where he is focused on building an organization that is well-positioned to positively contribute to improving the population’s health & well-being. Sheriff is a Vice President of Singapore Association of Pharmaceutical Industries (SAPI) and is member of the Board of Pharmaceutical Association of Malaysia (PhAMA). Sheriff joined MSD in 2020 where he led the global Sustainable Access Solutions (SAS) team responsible for advancing innovative commercial models to expand access to MSD’s medicines and vaccines around the world. Sheriff brings extensive and global experience of Healthcare systems and value based healthcare. Before joining MSD, Sheriff was with GE Healthcare where he started as Partner in GE Healthcare’s Consulting arm operating across Europe, Middle East, and Africa (EMEA), before transitioning to Executive, Partnerships & Solutions for GE Medical Systems in Europe. Prior to this, Sheriff spent many years in Consulting in the UK, working with multiple clients, particularly the UK NHS, and leading a range of strategic initiatives. Sheriff holds an Engineering Doctorate and a Master of Science from the Loughborough University in UK. He is married with three children. Outside of work, he enjoys reading and spending quality time with his family
Mr Ragunath 'Pak Joe' Murthy
Founder & Chief RainMaker, reAInmaker
“Ragunath “Pak Joe” Murthy is a seasoned leader with over 35 years of experience transforming the life insurance landscape across Asia Pacific.
From building multi-million-dollar agency networks to launching Asia’s first fully digital agency sales platform, he has held senior roles including Chief Agency Officer, Chief Distribution & Marketing Officer, and Chief Client Officer.
Today, as the Founder and Chief Rainmaker at reAInmaker, Pak Joe is pioneering AI-driven platforms like spAIder, butterflAIy, eaglAI, designed to elevate productivity and redefine business efficiency.
His work blends deep industry insight with cutting-edge tech to help organizations adapt and thrive.
A compelling speaker and change advocate, he is also an active contributor to community initiatives, serving as an Ambassador for the National Cancer Society Malaysia, Board of Trustees at My Shinning Star Foundation and Rotary International
Pak Joe’s philosophy is simple: after the rain, everything grows — including people, businesses, and ideas.
Mr Jonathan Teoh
Founder and CEO, KALSIS
Ragunath “Pak Joe” Murthy is a seasoned leader with over 35 years of experience transforming the life insurance landscape across Asia Pacific.
From building multi-million-dollar agency networks to launching Asia’s first fully digital agency sales platform, he has held senior roles including Chief Agency Officer, Chief Distribution & Marketing Officer, and Chief Client Officer.
Today, as the Founder and Chief Rainmaker at reAInmaker, Pak Joe is pioneering AI-driven platforms like spAIder, butterflAIy, eaglAI, designed to elevate productivity and redefine business efficiency.
His work blends deep industry insight with cutting-edge tech to help organizations adapt and thrive.
A compelling speaker and change advocate, he is also an active contributor to community initiatives, serving as an Ambassador for the National Cancer Society Malaysia, Board of Trustees at My Shinning Star Foundation and Rotary International
Pak Joe’s philosophy is simple: after the rain, everything grows — including people, businesses, and ideas
Mr Alex Xia
Alex has worked in a number of multinational manufacturing companies for more than 20 years and has been working around the world. He has been committed to providing financial solutions for patients since 2010.
Alex will share today the development of commercial health insurance in China over the past decade, the impact it has had on cancer patients, and the thoughts it has triggered.
Datuk Nuraslina Binti Zainal Abidin
Group Managing Director & Chief Executive Officer, Theta Edge Berhad
Datuk Nuraslina Zainal Abidin is a visionary corporate leader with over 18 years of experience driving transformation and business growth across major corporations. Currently serving as the Group Managing Director & Chief Executive Officer of Theta Edge Berhad. She has successfully led Theta’s expansion into FinTech, advancing digital payment and platform-based solutions in areas such as government accounting, land management, and hajj operations, positioning the Group as a leading digital solutions provider. Recognised as Malaysia’s Woman Corporate Leader of the Year in 2024, Datuk Nuraslina is also a passionate advocate for digital inclusivity, having spearheaded initiatives such as the Digitalising B40 Community Programme and the Digital Masjid Programme to empower underserved communities and promote financial transparency. Her impact extends beyond the corporate world, with a strong emphasis on innovation, financial resilience, and social impact, aligning with her mission to build a sustainable, technology-driven future for Theta Edge Berhad.
Mr Anesh Junak
Chief Product Officer, MCIS Life
Anesh is a qualified actuary and a Fellow of the Institute and Faculty of Actuaries. He currently serves as the Chief Product Officer at MCIS Life.
With over 22 years of experience across both life and general insurance in Malaysia and other emerging markets, Anesh has held a range of roles spanning technical actuarial functions, corporate strategy, pricing, and product development. For the past 13 years, he has taken on senior leadership roles, contributing to strategic growth and innovation across multiple organisations.
As Chief Product Officer, Anesh leads the product team, focusing on designing products that are not only financially sustainable but also relevant to the evolving needs of Malaysian policyholders. He plays a key role in aligning insurance offerings with broader customer experience strategies and regulatory expectations.
Anesh is deeply passionate about developing people and building high-performing, purpose-driven teams. He is a strong advocate for cross-industry collaboration and believes that innovation in insurance often comes from engaging with partners beyond the traditional financial services space.
Ms Dayang Miraffiorry Abu Husain
Childhood Cancer Program Coordinator, National Cancer Society Malaysia
Dayang Miraffiorry is the Childhood Cancer Program Manager at the National Cancer Society Malaysia. With a background in operations management, training development, and project management, she leads initiatives that support children with cancer and their caregivers through education, support services, and community engagement. Dayang also works on fundraising and resource mobilization, and collaborates with state-based groups to run advocacy campaigns, workshops, and events to improve public understanding and patient experiences.
Dr Vaishnavi Jeyasingam
Consultant Clinical Oncologist
Dr Vaishnavi Jeyasingam is a Consultant Clinical Oncologist at the Radiotherapy and Oncology Department, Hospital Kuala Lumpur, with over a decade of experience in oncology care. She graduated with an MBBS from the University of Malaya in 2005, receiving the Dean’s List award, and later obtained her Master’s in Clinical Oncology from the same institution. She completed a clinical attachment at the Head and Neck Radiation Unit, Princess Alexandra Hospital in Brisbane, Australia.
Her clinical interests include breast cancer, head and neck radiation, and hematological malignancies, and she also serves sessionally at ParkCity Medical Centre and Subang Jaya Medical Centre. Dr Vaishnavi is a supervisor and external examiner for the Master’s in Clinical Oncology programme at University Malaya and contributes to national oncology curriculum development. She is also an active panel member for clinical practice guidelines and patient access programmes, reflecting her commitment to advancing oncology care and education in Malaysia.